Abstract
Loss or downregulation of human leukocyte antigen (HLA) class I molecules is a widespread mechanism used by tumor cells to avoid tumor recognition by cytotoxic T lymphocytes favoring tumor immune escape. Multiple molecular mechanisms are responsible for these altered HLA class I tumor phenotypes, such as the loss of heterozygosity (LOH) at chromosome region 6p21.3. In this study, we used immunohistological techniques with a highly selective panel of anti-HLA monoclonal antibodies to analyze the expression of HLA class I molecules in 84 formalin-fixed, paraffin-embedded section and 49 frozen-fresh tissues of primary esophageal squamous cell carcinomas (pESCC) from Chinese patients. To elucidate the underlying mechanism of HLA class I loss or downregulation, we also analyzed LOH of previously selected microsatellite markers located in chromosomes 6 and 15 by polymerase chain reaction. DNA was obtained from frozen-fresh tumor tissues and surrounding stroma to define the LOH associated with chromosomes 6p21 and 15q21. Our results showed that HLA-A, HLA-B/C, HLA class I heavy chain, beta2-microglobuline, and HLA class I complex were lost or downregulated in pESCC (P<0.0001), and were moderately associated with the microsatellite alt...Continue Reading
References
May 1, 1978·Cell·C J BarnstableA Ziegler
Jun 1, 1992·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S R ShiA K Tandon
Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A MittelmanS Ferrone
Jan 1, 1991·International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement·V MattijssenD J Ruiter
Oct 1, 1993·Immunology Today·F GarridoP L Stern
Jun 1, 1996·Tropical Medicine & International Health : TM & IH·S Katzwinkel-WladarschH Rinder
Feb 1, 1997·Immunology Today·F GarridoP L Stern
May 16, 1998·Tissue Antigens·G TamiyaH Inoko
Aug 7, 1998·Tissue Antigens·L A KoopmanG J Fleuren
Aug 7, 1998·Molecular Immunology·M F SerneeD J Schust
Jun 22, 1999·Oncology Reports·N MazurenkoF Kisseljov
Oct 16, 1999·Tissue Antigens·M FeenstraM Tilanus
Mar 23, 2000·The Journal of Experimental Medicine·L A KoopmanG J Fleuren
Apr 1, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·M FeenstraM Tilanus
Jul 8, 2000·Tissue Antigens·C S BradyP L Stern
Jul 8, 2000·Tissue Antigens·L M RamalF Garrido
Sep 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S A DesaiS Ferrone
Feb 17, 2001·The Journal of Pathology·T OwonikokoM Sarbia
Sep 29, 2001·Carcinogenesis·Y NieC S Yang
Apr 30, 2002·Genes, Chromosomes & Cancer·Qiang HuangStimson P Schantz
Jan 22, 2003·Cancer Immunology, Immunotherapy : CII·Teresa CabreraFederico Garrido
Jan 28, 2003·The American Journal of Pathology·El Chérif IbrahimPascale Paul
Apr 22, 2003·Journal of Cellular Physiology·Angel Garcia-LoraFederico Garrido
Apr 25, 2003·Cancer·Eric C WeinmanScott E Strome
Aug 2, 2003·Tissue Antigens·X WangS Ferrone
Sep 14, 2004·Tissue Antigens·G J P A KoeneM G J Tilanus
Citations
Mar 19, 2013·International Journal of Cancer. Journal International Du Cancer·Polat DuraWilbert H M Peters
Oct 24, 2013·Asia-Pacific Journal of Clinical Oncology·Biao FengLiwei Zhang
Jan 4, 2012·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Josefa Antonia RodríguezAlba Lucía Combita
May 12, 2017·PloS One·Peng ZhangLi-Dong Wang
May 24, 2019·Frontiers in Genetics·Marco MatejcicM Iqbal Parker
Mar 27, 2021·Frontiers in Immunology·Karthik DhatchinamoorthyKenneth L Rock
Aug 28, 2021·Frontiers in Immunology·Ding-Kang WangBin Li